Related Experiment Videos
How to avoid cardiac ischemic events associated with aortic surgery.
1Division of Vascular Surgery, Department of Surgery, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262, USA.
Seminars in Vascular Surgery
|December 12, 2001
Summary
Preoperative cardiac evaluation before vascular surgery can lead to complications. Beta-blocker therapy significantly reduces cardiac events in patients with coronary artery disease (CAD).
Area of Science:
- Cardiology
- Vascular Surgery
- Perioperative Medicine
Background:
- Coronary artery disease (CAD) is common in patients needing vascular surgery, but consensus on preventing perioperative cardiac ischemic events is lacking.
- Adverse cardiac outcomes occur frequently after infrainguinal operations, similar to aortic procedures, making findings relevant across vascular surgery types.
Purpose of the Study:
- To analyze adverse outcomes associated with preoperative cardiac evaluation and intervention in vascular surgery patients.
- To review current strategies for preoperative cardiac testing and management of CAD in vascular surgery.
Main Methods:
- Retrospective analysis of 153 patients undergoing vascular procedures at the Denver Department of Veterans Affairs Medical Center.
- Review of existing literature and ongoing trials (e.g., CARP trial) on cardiac evaluation and management strategies.
Main Results:
- Of 42 patients with extended cardiac evaluations, 16 (38%) experienced untoward events.
- Extensive cardiac evaluation can lead to morbidity, delays, and patient refusal of necessary vascular surgery.
- Perioperative beta-blocker therapy has been shown to reduce adverse cardiac outcomes by 55% in vascular patients with CAD.
Conclusions:
- The risks of preoperative cardiac evaluation and intervention must be weighed against potential benefits, considering the primary surgical indication and local complication rates.
- Perioperative beta-adrenergic blockade is a proven strategy to mitigate cardiac risk in vascular surgery patients with CAD.
- Further research, like the CARP trial, is needed to compare invasive cardiac intervention versus best medical care for these patients.